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Cardiolo~ (1990) 22,000400. Our earlier work on reperfusion showed that adult rat hearts released almost twice 
as much purine nucleosides and oxypurines as newborn hearts did [Am J Physiol 254 (1988) Hl091]. A change 
in the ratio anabolism/catabolism of adenosine could be responsible for this effect. We therefore measured the 
activity of adenosine kinase, adenosine deaminase, nucleoside phosphorylase and xanthine oxidoreductase in 
homogenates of hearts and myocytes from neonatal and adult rats. In hearts the activity ofadenosine deaminase 
and nucleoside phosphorylase (IO-20 U/g protein) changed relatively little. However, adenosine kinase activity 
decreased from 1.3 to 0.6 U/g (P<O.O25), and xanthine oxidoreductase activity increased from 0.02 to 0.85 U/g 
(P< 0.005). Thus the ratio in activity of these rate-limiting enzymes for anabolism and catabolism dropped from 
68 to 0.68 during cardiac development. In contrast, the ratio in myocytes remained unchanged (about 23). The 
large difference in adenosine anabolism/catabolism ratio, observed in heart homogenates, could explain why 
ATP breakdown due to hypoxia is lower in neonatal than in adult heart. Because this change is absent in 
myocytes, we speculate that mainly endothelial activities of adenosine kinase and xanthine oxidoreductase are 
responsible for this shift in purine metabolism during development. 
KEY WORDS: Adenosine deaminase; Adenosine kinase; Adult; Age; Development; Myocyte; Neonate; Nucleoside 
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Introduction 
ATP metabolism plays an important role in 
myocardial function, e.g., contractility, ion 
transport, vasodilation. Most studies on this 
topic focus on adult heart. Consequently, rela- 
tively little is known about ATP metabolism 
in the newborn heart. We showed recently 
large age-related differences in cardiac purine 
release following ischemia [I]. We hypothe- 
sized that a change in anabolic/catabolic 
pathways of adenosine was responsible for this 
phenomenon. Therefore, we studied the activ- 
ity of adenosine kinase, adenosine deaminase, 
nucleoside phosphorylase and xanthine 
oxidoreductase in (homogenates of) rat hearts 
and cardiomyocytes. Part of the results has 
been published in abstract form [13]. 
Materials and Methods 
Chemicals 
All chemicals used were of the highest grade 
available. Adenosine, inosine, hypoxanthine 
and uric acid were supplied by Janssen 
Chimica (Beerse, Belgium). Xanthine and [8- 
r4C]xanthine were from Boehringer (Mann- 
heim, FRG) and Amersham (Little Chalfont, 
UK), respectively. Collagenase, hyaluronid- 
ase and calf serum were bought from Boehrin- 
ger, Ml99 cell culture medium from Gibco 
(Paisley, UK). 5’-Iodotubercidine was ob- 
tained from Research Biochemicals (Natick, 
MA., USA), erythro-9-(2-hydroxy-3- 
nonyl)adenine*HCl from Burroughs 
Wellcome (Research Triangle Park, N.C., 
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USA), alpha, beta-methylene-adenosine-5’- 
diphosphate and bovine serum albumin from 
Sigma (St. Louis, MO., USA). Allopurinol 
came from Wellcome (Beckenham, UK). 
Neonatal Preparations 
Hearts were used of Sprague-Dawley rats 
(two days old; IFFA-Credo, Lyon, France). 
The sucklings were killed by decapitation. For 
the preparation of heart homogenates (5% 
w/v), a pool of ten ventricles was washed with 
154 mM NaCl, 0°C then minced in a Virtis 
blender and a Potter-Elvehjem homogenizer 
at 0°C. The homogenization buffer consisted 
of: 10 mM Tricine, 1 mM EDTA, 0.25 M suc- 
rose, pH 7.4. Homogenates were stored below 
-80°C. Neonatal cells were prepared and 
cultured according to Link et al. [20]. My- 
ocytes were separated from non-muscular cells 
with the method of Blonde1 et al. [q. After a 
culture period of 2 days, the cells were 
washed three times with 154 mM NaCl, 
scraped from the Petri dishes into the homo- 
genization buffer, and stored in liquid nitro- 
gen. The purity of the cell culture was about 
80% (May-Griinwald staining). 
Adult preparations 
Adult rats (about four months old; source: see 
above) were sedated intraperitoneally with 
30-60 mg pentobarbitone. The hearts were 
isolated and the atria removed. To eliminate 
blood, the hearts were flushed retrogradely 
with 154 mM NaCl. The ventricles were homo- 
genized essentially as described for the neo- 
natal hearts. For the preparation of cardiomy- 
ocytes, the procedure of Farmer et al. [16] was 
partly followed. A modified Tyrode solution 
[17] was used with 0.1 y. collagenase, 0.1 y. 
hyaluronidase, 0.1% albumin and 50 pM 
CaCls [Ia. Hearts were perfused with this 
solution in a recirculating way at 37°C for 
30-40 min [21]. Then the ventricles were cut 
from the perfusion apparatus and torn apart 
using two forceps. After 10 min incubation 
with the Tyrode solution (albumin raised to 
l%), the remainder of the tissue was gently 
suspended further with a serological lo-ml 
pipette [21] and filtered through a 200-pm 
mesh sieve. The cells were washed in the 
Tyrode solution (no enzymes, 2% albumin, 
sterile [16]) once at 1 x g and twice at 12 x g 
for 1 min. Subsequently, the cells were 
suspended in sterile Ml99 medium, contain- 
ing 4% fetal calf serum. They were purified 
using the method of Piper et al. [22] and kept 
in culture for 1 day. Then the cells were 
collected in homogenization buffer and stored 
in liquid nitrogen. With phase-contrast micro- 
scopy, only myocytes could be detected in the 
preparation. 
Assays 
Just before the assay of the (cytosolic) en- 
zymes, carried out at 30°C the samples (2-5 
ml) were thawed, sonicated (M2/70, MSE, 
Crawley, UK) twice at 0°C for 30 s, and spun 
in a Mikroliter centrifuge (Hettich, Tuttlin- 
gen, FRG) at 4°C for 5 min. Adenosine kinase 
was assayed with the radiometric method de- 
scribed by De Jong et al. [21,22]. Adenosine 
deaminase activity was determined according 
to Coddington et al. [8], using 45 PM aden- 
osine. If the activity was too low for detection 
with the Hitachi U-2000 double-beam spec- 
trophotometer, products were measured by 
high-performance liquid chromatography 
[18]. Nucleoside phosphorylase was .tieter- 
mined at 293 nm, using 0.1 M K-PO4 pH 7.4, 
0.25 mM inosine and 0.2 U xanthine 
oxidoreductase (see Boehringer catalogue). 
Xanthine oxidoreductase was measured ac- 
cording to Schoutsen et al. [23l. Protein was 
assayed with Coomassie Brilliant Blue (Bio- 
Rad Laboratories, Munich, FRG) according 
to Bradford [a, using bovine serum albumin 
as the standard. 
Statistics 
Statistical analysis was done with Student’s t- 
test for unpaired variates (two-tailed). Data 
are given as means f S.E. Differences with 
P < 0.05 were considered significant. 
Results 
The adenosine kinase activity measured in 
ventricular homogenates decreased from 
1.3 ) 0.2 U/g protein in neonatal hearts to 
0.58 + 0.12 U/g (P < 0.025) in adult hearts 
(Fig. 1). In isolated myocytes it also decreased 
about two-fold with increasing age (Fig. 1). In 
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FIGURE 1. Adenosine kinase activities in ventricles 
and myocytes from neonatal (open bars) and adult 
(hatched bars) rat hearts. Mean values are given with S.E. 
(n = 6). *P < 0.025 vs. neonatal. 
neonatal heart cells, we measured 1.02 fO.10 
U/g, in adult cells 0.56 ) 0.06 U/g 
(P < 0.005). The specific activities of the ven- 
tricular and myocyte preparations did not 
differ significantly. 
The adenosine deaminase activity in ven- 
tricular homogenates was unaffected by age: 
12.9 f 1.1 U/g protein in neonatal hearts and 
10.9 f 0.2 U/g in adult hearts (Fig. 2). How- 
ever, isolated myocytes differed in this respect: 
6.8 + 0.6 U/g (neonatal) versus 2.6 & 0.2 U/g 
(adult, P < 0.001). The specific activity in 
both cell preparations was lower (P < 0.001) 
than that in the ventricular preparations. 
The activity of nucleoside phosphorylase 
decreased from 20.6 &- 1.9 U/g protein in neo- 
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FIGURE 3. Nucleoside phosphorylase activities in ven- 
tricles and myocytes from neonatal (open barsi and adult 
(hatched bars) hearts. Mean values with S.E. ;n = 3--6 I. 
*P < 0.025 vs. neonatal: *P < 0.001 vs. whole heart. 
natal hearts to 15.1 + 0.6 U/g (P < 0.025) in 
adult hearts (Fig. 3). We found 10.0 f 0.7 
U/g in neonatal myocytes, which was lower 
(P<O.OOl) than that in whole hearts. Nucleo- 
side phosphorylase activity in adult myocytes 
(12 ) 3 U/g) did not differ significantly from 
that in neonatal myocytes or adult hearts. 
In heart homogenates xanthine oxido- 
reductase increased in activity during de- 
velopment from 0.018 + 0.008 to 0.85 + 0.15 
U/g protein (P < 0.005, Fig. 4). In contrast, 
this change was absent in myocytes: 
0.042 & 0.015 u/g (neonatal cells), 
0.026 + 0.017 U/g (adult cells). 
To check the specificity of the enzyme reac- 
tions studied, we tested several inhibitors in 
Xanthme oxidoreductose 
l/a moteIn) 
FIGURE 2. Adenosine deaminase activities in ven- FIGURE 4. Xanthine oxidoreductase activities in ven- 
tricles and myocytes from neonatal (open bars) and adult tricles and myocytes from neonatal (open bars) and adult 
(hatched bars) hearts. Mean values with S.E. (n = 54). 
*P<O.OOl vs. neonatal; 'P < 0.001 vs. whole heart. 
(hatched bars) hearts. Mean values with S.E. (n = 4di. 
*P < 0.005 vs. neonatal; 'P < 0.005 vs. whole heart. 
1068 J. W. de Jong et al. 
both neonatal and adult heart preparations. 
Erythro-9-(2-hydroxy-3-nonyl)adenine (10 
PM) inhibited the adenosine deaminase 
activity by 98%, 5’-iodotubercidine (5 PM) 
that of adenosine kinase by 96% [9]. Addition 
of the adenosine deaminase inhibitor [2.5j or 
alpha,beta-methylene-adenosine-5’- 
diphosphate (50 PM), a 5’-nucleotidase inhibi- 
tor [25j, did not stimulate the adenosine 
kinase reaction, showing that adenosine 
deaminase and 5’-nucleotidase did not inter- 
fere with the assay. Allopurinol (100 PM) in- 
hibited the xanthine oxidoreductase activity 
> 98% [28]. 
Discussion 
A number of cardiac enzymes involved in 
ATP breakdown vary with age [24,27J. Dur- 
ing hypoxia nucleotides catabolize to purines, 
which may cross cell membranes. Using neo- 
natal and adult heart, we compared the activ- 
ities of adenosine kinase and adenosine deami- 
nase, enzymes sharing adenosine as a sub- 
strate. In addition we measured nucleoside 
phosphorylase and xanthine oxidoreductase, 
enzymes responsible for the ultimate break- 
down of nucleosides. We do not know whether 
the different enzymic activities observed are 
due to different amounts of enzymes; xanthine 
oxidoreductase can occur in an inactive form 
[2Gj. The inhibitor studies proved that our 
enzymic assays were specific. 
Adenosine kinase and adenosine deaminase 
A new finding is the difference in adenosine 
kinase activity between neonatal and 4-month 
old ventricles (Fig. 1). The activity in the 
latter had decreased more than twice. We 
found this chhnge also in isolated cardiomy- 
ocytes. Regardless of age, the specific activities 
in whole heart and myocytes were similar. 
This indicates that the bulk of adenosine 
kinase is present in the myocytes, which make 
up most of the cardiac mass. 
The adenosine deaminase activity in hearts 
and myocytes was substantially higher than 
that of adenosine kinase (cJ Figs 1 and 2). It 
explains why deamination exceeds phos- 
phorylation of adenosine in isolated, perfused 
hearts [IO]. The enzymic measurements con- 
firm the results of Arch and Newsholme [3j 
obtained in adult rat hearts. However, they 
contrast data from Dow et al. [25] who re- 
ported equal activities of the two enzymes in 
adult cardiomyoctes. The discrepancy is prob- 
ably due to the difference in assay temperature 
used (see ref. 2). 
The activities of adenosine deaminase in 
neonatal and adult hearts did not differ (Fig. 
2), confirming literature data [271. On the 
other hand, the specific activity in neonatal 
myocytes was about half of that in heart 
homogenates; it decreased 60% during devel- 
opment (Fig. 2). This indicates that adenosine 
deaminase activity is not evenly distributed 
among cardiac cells, especially in adult heart. 
Similarly, Dow et al. [25] stated that most of 
the myocardial adenosine deaminase is not 
located in (adult) myocytes. We postulate that 
this catabolic activity resides mainly in the 
endothelial cells. 
Nucleoside phosphorylase and xanthine 
oxidoreductase 
Nucleoside phosphorylase activity in adult 
heart was somewhat lower than in neonatal 
heart (Fig. 3). This finding is in agreement 
with published data [27j. Neonatal myocytes 
contained half the activity observed in heart 
homogenates. The adult ventricular and cel- 
lular preparations showed comparable activ- 
ity. We conclude that the early preponderance 
of nucleoside phosphorylase activity in non- 
cardiac cells disappears later in life. We doubt 
that the enzyme in rat heart is predominantly 
located in endothelial cells, contrasting data 
for guinea-pig heart [22]. 
The data in Figure 4 confirm our earlier 
reports that xanthine oxidoreductase activity 
increases age-dependently [24]. Apparently 
this rise takes place almost exclusively outside 
the cardiomyocytes (Fig. 4), presumably in 
the microvascular endothelium [4,19]. We like 
to stress that xanthine oxidoreductase shows 
little activity in the (adult) heart of several 
species, including man [14]. 
Anabolism versus catabolism 
The specific activities of adenosine kinase and 
xanthine oxidoreductase were more than ten 
times lower than those of the other enzymes. 
During development the ratio of the former, 
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rate-limiting enzymes for anabolism and oxidoreductase are responsible for this shift in 
catabolism, dropped from 68 to 0.68 in ven- purine metabolism during development. 
tricles. In contrast, the ratio in myocytes re- Could the urate produced by the adult heart 
mained unchanged, i.e., about 23. We con- of some species act as a radical scavenger and 
elude that the large difference, observed in antioxidant [2,5J? 
heart homogenates, explains why ATP break- 
down due to hypoxia is less in neonatal than in 
adult heart. Because this change is absent in Acknowledgement 
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